Cargando…
FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients
Hypoxia is a characteristic feature of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC). We have recently explored new targeting molecules and pathways in PDAC cells under hypoxic conditions. In this study, we performed a microarray experiment to analyze the genes up-regulated i...
Autores principales: | Saeki, Kiyoshi, Onishi, Hideya, Koga, Satoko, Ichimiya, Shu, Nakayama, Kazunori, Oyama, Yasuhiro, Kawamoto, Makoto, Sakihama, Kukiko, Yamamoto, Takeo, Matsuda, Ryota, Miyasaka, Yoshihiro, Nakamura, Masafumi, Oda, Yoshinao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052938/ https://www.ncbi.nlm.nih.gov/pubmed/32127956 http://dx.doi.org/10.7150/jca.38399 |
Ejemplares similares
-
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer
por: Ichimiya, Shu, et al.
Publicado: (2021) -
C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions
por: Nagao, Shinjiro, et al.
Publicado: (2023) -
Intrapancreatic recurrence of intraductal tubulopapillary neoplasm (ITPN) 16 years after the initial surgery for noninvasive ITPN: a case report
por: Saeki, Kiyoshi, et al.
Publicado: (2018) -
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor
por: Koga, Satoko, et al.
Publicado: (2021) -
Corrigendum to “PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor” [Volume 14, Issue 9, September 2021, 101152]
por: Koga, Satoko, et al.
Publicado: (2022)